XellSmart Secures Dual FDA, NMPA IND for MSA-P
SUZHOU, China, March 2, 2026 XellSmart Pharmaceutical Co., Ltd. announced that it has received its fourth consecutive Investigational New...
Regenerative Medicine
FDA Clears Collagen Scaffold Device for Wound Care
ROSWELL, Ga., Feb. 12, 2026 — StimLabs announced that the U.S. Food and Drug Administration has granted 510(k) clearance...
FibroBiologics to Spotlight Cell Therapy at H-SPAN Summit
Houston, Texas — February 10, 2026: FibroBiologics, Inc., a clinical-stage biotechnology company advancing fibroblast-based therapeutics, announced that its Chairman...
Regentis Expands Phase III GelrinC Trial Across U.S. Sites
HERZLIYA, Israel, January 29, 2026 — Regentis Biomaterials Ltd. announced a significant expansion of its U.S. clinical site network...
FibroBiologics to Present at Global Healthcare Investment Forum
HOUSTON | January 6, 2026 — FibroBiologics, Inc. announced that its Founder and Chief Executive Officer will present at...
Longeveron Joins Alzheimer’s Moonshot at JPM 2026
MIAMI, Fla., December 29, 2025 — Longeveron Inc., a clinical-stage biotechnology company developing regenerative cell therapies, has been selected...
FDA Clears StimLabs’ Theracor, First Umbilical Cord Sheet
ROSWELL, Ga., December 29, 2025 — StimLabs has announced that the U.S. Food and Drug Administration (FDA) has granted...
Celularity Strengthens Platform With Strategic Financing Close
Florham Park, New Jersey | December 22, 2025 — Celularity Inc., a regenerative and cellular medicine company focused on...
MEDIPOST Secures Japan Commercial Deal for CARTISTEM® Therapy
Seoul, South Korea, December 19, 2025 — MEDIPOST Co., Ltd., a fully integrated cell therapy biotechnology company, has entered...
Axogen to Showcase Nerve Repair Innovation at JPM 2026
ALACHUA, Fla. and TAMPA, Fla., Dec. 17, 2025 — Axogen, Inc. (NASDAQ: AXGN), a recognized leader in peripheral nerve...